New Enhancements To AstraZeneca’s Medicare Part D Patient Assistance Program
By Earl Whipple At AstraZeneca, we know the most important step we can take to improve healthcare is to continue building a pipeline of valued medicines that make a meaningful difference in patients’...
View ArticleOur Fair Share: Closing the Coverage Gap
Bloomberg takes a look at upcoming prescription medicine savings for Medicare patients in a story headlined “Drugmakers’ ‘Doughnut Hole’ Deal on Overhaul to Shave Sales Less Than 1%.” The story...
View ArticleMedicare Part D: A Success Story
This week the Centers for Medicare & Medicaid Services (CMS) posted data that shows beneficiaries in the Medicare prescription drug program are accessing the medicines they need and saving money as...
View ArticleMedicare, jobs and our industry
A new report underscores a tie between the health of the biopharmaceutical industry and the American economy that must be considered as our nation’s leaders negotiate an important agreement on the debt...
View ArticleSavings for seniors in Medicare Part D
A study published in today’s Journal of the American Medical Association found that American seniors’ increased access to medicines via the Medicare prescription drug program led to reduced spending on...
View Article2012 Medicare premiums steady; industry supports program
Federal health officials announced today that the national average Medicare prescription drug premium will not increase next year, thanks in part to competition built into the system. Bloomberg...
View ArticleFilling the donut hole: why it matters
A new study of the Medicare prescription drug benefit found that patients who enter the “donut hole” or coverage gap are twice as likely to discontinue their medications as they are to switch to more...
View ArticleFormer HHS Secretary: Medicare drug benefit is working
Former HHS Secretary Tommy G. Thompson says the Medicare drug benefit is working for patients. Former US Department of Health and Human Services Secretary Tommy G. Thompson took the time to answer a...
View ArticleThe Medicare prescription drug benefit works
AstraZeneca is focused on the success and value of the Medicare prescription drug benefit to patients. Today, more than 29 million Medicare beneficiaries are enrolled in a Part D plan, and 90 percent...
View Article2012 Medicare open enrollment comes early
Medicare’s open enrollment period is just two days away – are you ready? Whether you are a beneficiary, a caregiver or know someone who is, you can help spread the word about Medicare open enrollment...
View ArticleSeniors satisfied with Medicare prescription drug program
The Medicare prescription drug benefit is working well for America’s seniors. A new survey of seniors by the Medicare Today coalition provides additional evidence that the Medicare prescription drug...
View ArticleSeniors and the donut hole
American seniors have increased access to medicines via the Medicare prescription drug program. The Medicare prescription drug benefit for seniors and the disabled is saving them money while helping...
View ArticleCongress Should Repeal IPAB
Congress should approve HR 452. AstraZeneca is urging Congress to support legislation sponsored by Rep. Phil Roe that would repeal the Independent Payment Advisory Board (IPAB) established by the...
View ArticleSeniors satisfied with Medicare prescription drug program
Seniors overwhelmingly approve of the Medicare prescription drug benefit. Medicare Today released its 2012 beneficiary satisfaction survey results Wednesday, providing additional evidence that the...
View Article2013 Medicare premiums steady as open enrollment begins
Time to talk Medicare: Open enrollment begins on October 15 and runs through December 7. It’s that time of year again – open enrollment period for the Medicare program, allowing seniors and other...
View ArticleIncreased Rx use offsets medical services costs in Medicare
Analysis shows a link between changes in Rx drug use and changes in the use of and spending for medical services. A new report by The Congressional Budget Office (CBO) recognizes the effect of...
View ArticleNational Council on Aging honors AstraZeneca
Linda Palczuk, Vice President, Cornerstone and Commercial Excellence, accepted the award on behalf of AstraZeneca In 2007, the National Council on Aging, with support from AstraZeneca, created My...
View ArticleMedicare Part D: Don’t Mess with Success
If imitation is the greatest form of flattery, then the federal government should be flattered that states have begun using the market-based structure of the highly successful Medicare Part D program...
View ArticleSurvey: Medicare Rx program highly popular
The Medicare prescription drug benefit is still popular after all these years. Nine in 10 seniors with Medicare prescription drug coverage are satisfied with the program, and 97 percent said their...
View ArticleTake Time to Evaluate Options During Medicare Part D Enrollment
With Medicare enrollment now open, seniors across the country have an opportunity to select the Part D prescription drug plan that best suits their needs and budgets – and that may mean making a change...
View Article
More Pages to Explore .....